MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with V

Vildagliptin

Vildagliptin 50mg tablets

Use with caution

Stability notes for Vildagliptin 50mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container. Original packaging may contain desiccant. No stability data in MCAs available.

Provenance

This recommendation is based on the products Galvus 50mg tablets (Novartis Pharmaceuticals UK Ltd) and vildagliptin 50mg tablets (Amarox Limited).

Suppliers (11) of Vildagliptin 50mg tablets
Galvus 50mg tablets (CST Pharma Ltd)
Galvus 50mg tablets (Novartis Pharmaceuticals UK Ltd)
Vildagliptin 50mg tablets (A A H Pharmaceuticals Ltd)
Vildagliptin 50mg tablets (Accord-UK Ltd)
Vildagliptin 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Vildagliptin 50mg tablets (Amarox Ltd)
Vildagliptin 50mg tablets (Milpharm Ltd)
Vildagliptin 50mg tablets (MSN Laboratories Europe Ltd)
Vildagliptin 50mg tablets (Novumgen Ltd)
Vildagliptin 50mg tablets (Teva UK Ltd)
Vildagliptin 50mg tablets (Torrent Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.